Search research articles
Contact Us
Filters
Showing results (51-60 of 248) with videos related to
Page
of 25
Sort By:
Malaria Journal
|
July 5, 2011
Optimal designs for population pharmacokinetic studies of oral artesunate in patients with uncomplicated falciparum malaria
Kris M Jamsen, Stephen B Duffull, Joel Tarning, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
November 9, 2013
Liquid chromatographic-mass spectrometric method for simultaneous determination of small organic acids potentially contributing to acidosis in severe malaria
Natthida Sriboonvorakul, Natchanun Leepipatpiboon, Arjen M Dondorp, et al.
British Journal of Clinical Pharmacology
|
January 27, 2016
Population pharmacokinetics of oseltamivir and oseltamivir carboxylate in obese and non-obese volunteers
Kalayanee Chairat, Podjanee Jittamala, Warunee Hanpithakpong, et al.
Antimicrobial Agents and Chemotherapy
|
March 20, 2013
Comparison of oseltamivir and oseltamivir carboxylate concentrations in venous plasma, venous blood, and capillary blood in healthy volunteers
Insti Instiaty, Niklas Lindegardh, Podjanee Jittmala, et al.
Antimicrobial Agents and Chemotherapy
|
January 8, 2020
High-Dose Chloroquine for Uncomplicated Plasmodium falciparum Malaria Is Well Tolerated and Causes Similar QT Interval Prolongation as Standard-Dose Chloroquine in Children
Johan Ursing, Lars Rombo, Staffan Eksborg, et al.
Antimicrobial Agents and Chemotherapy
|
November 24, 2005
Pitfalls in estimating piperaquine elimination
Joel Tarning, Niklas Lindegårdh, Anna Annerberg, et al.
The Journal of Infectious Diseases
|
December 11, 2012
Plasmodium falciparum drug resistance phenotype as assessed by patient antimalarial drug levels and its association with pfmdr1 polymorphisms
Maja Malmberg, Pedro E Ferreira, Joel Tarning, et al.
Plos Medicine
|
September 4, 2020
COVID-19 prevention and treatment: A critical analysis of chloroquine and hydroxychloroquine clinical pharmacology
Nicholas J White, James A Watson, Richard M Hoglund, et al.
Plos Neglected Tropical Diseases
|
February 21, 2024
Identification of trans-genus biomarkers for early diagnosis of intestinal schistosomiasis and progression of gut pathology in a mouse model using metabolomics
Peerut Chienwichai, Phornpimon Tipthara, Joel Tarning, et al.
Annual Review of Pharmacology and Toxicology
|
October 10, 2017
Model-Informed Drug Development for Malaria Therapeutics
Kayla Ann Andrews, David Wesche, James McCarthy, et al.
Page
of 25
Search research articles
Search
Showing results (51-60 of 248) with videos related to
Sort By:
Page
of 25
Malaria Journal
|
July 5, 2011
Optimal designs for population pharmacokinetic studies of oral artesunate in patients with uncomplicated falciparum malaria
Kris M Jamsen, Stephen B Duffull, Joel Tarning, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
November 9, 2013
Liquid chromatographic-mass spectrometric method for simultaneous determination of small organic acids potentially contributing to acidosis in severe malaria
Natthida Sriboonvorakul, Natchanun Leepipatpiboon, Arjen M Dondorp, et al.
British Journal of Clinical Pharmacology
|
January 27, 2016
Population pharmacokinetics of oseltamivir and oseltamivir carboxylate in obese and non-obese volunteers
Kalayanee Chairat, Podjanee Jittamala, Warunee Hanpithakpong, et al.
Antimicrobial Agents and Chemotherapy
|
March 20, 2013
Comparison of oseltamivir and oseltamivir carboxylate concentrations in venous plasma, venous blood, and capillary blood in healthy volunteers
Insti Instiaty, Niklas Lindegardh, Podjanee Jittmala, et al.
Antimicrobial Agents and Chemotherapy
|
January 8, 2020
High-Dose Chloroquine for Uncomplicated Plasmodium falciparum Malaria Is Well Tolerated and Causes Similar QT Interval Prolongation as Standard-Dose Chloroquine in Children
Johan Ursing, Lars Rombo, Staffan Eksborg, et al.
Antimicrobial Agents and Chemotherapy
|
November 24, 2005
Pitfalls in estimating piperaquine elimination
Joel Tarning, Niklas Lindegårdh, Anna Annerberg, et al.
The Journal of Infectious Diseases
|
December 11, 2012
Plasmodium falciparum drug resistance phenotype as assessed by patient antimalarial drug levels and its association with pfmdr1 polymorphisms
Maja Malmberg, Pedro E Ferreira, Joel Tarning, et al.
Plos Medicine
|
September 4, 2020
COVID-19 prevention and treatment: A critical analysis of chloroquine and hydroxychloroquine clinical pharmacology
Nicholas J White, James A Watson, Richard M Hoglund, et al.
Plos Neglected Tropical Diseases
|
February 21, 2024
Identification of trans-genus biomarkers for early diagnosis of intestinal schistosomiasis and progression of gut pathology in a mouse model using metabolomics
Peerut Chienwichai, Phornpimon Tipthara, Joel Tarning, et al.
Annual Review of Pharmacology and Toxicology
|
October 10, 2017
Model-Informed Drug Development for Malaria Therapeutics
Kayla Ann Andrews, David Wesche, James McCarthy, et al.
Page
of 25